TYPE 1 DIABETES (T1D)
TREATMENT
About the Disease
Type 1 Diabetes (T1D) is a chronic autoimmune condition in which the body's T lymphocyte cells attack healthy beta cells that produce and secrete insulin. More than 10% of the United States population has diabetes; T1D makes up 6% of this group. Although they often are grouped together, T1D is of autoimmune origin, while type 2 diabetes is a metabolic disease. T1D is a growing problem, with an estimated five million people in the U.S. being diagnosed by 2050. Those at the highest risk for the disease are people with two or more T1D-related autoantibodies and abnormal blood sugar levels.
About our Patient Care
Our dedicated Care Team will work with the physician's office and insurance on a patient's behalf to give our patients more time to focus on their treatment and quality of life. We are here to listen, provide counseling on treatment, including side-effect management, and assist with sourcing third-party financial assistance. In addition, Orsini is one of the specialty pharmacies selected to provide patients with access to an FDA-approved, monoclonal antibody infusion therapy.
As part of treatment, we provide:
Dedicated Care Team
We provide prescribers and patients with a dedicated Care Team, including a primary pharmacy contact, clinical education, side-effects management, scheduled refill calls, and a direct phone, fax, and email address.
In-Home Patient- and Family-Centric Care
We administer a nationwide nursing network, allowing patients to pursue in-home treatment. Our nurses are ideally positioned to establish a partnership with patients and their families in order to provide clinical education and coaching that strengthen the patient's capacity to achieve therapy goals.
Shipping and Coordination of Care
We provide free overnight delivery of medications and manage the coordination of care between prescribers, sites of care and patients to ensure dispenses and drug delivery align with the date and location of service.
Financial Assistance
We successfully identify and assist in enrolling patients into manufacturer co-pay and foundation support programs to minimize a potential financial burden to patients given the high cost of specialty medications.
24/7/365 Access to a Pharmacist
We provide prescribers and patients access to a pharmacist 24/7/365 to ensure patients always have access to the care they need.
Supported Treatments
Click on the specialty drug name below to expand and see more information.
TZIELD® (teplizumab)
Brand Name | TZIELD® (teplizumab)
Manufacturer | Provention Bio
Route of Administration | Intravenous infusion
Approved Indication | Indicated to delay the onset of stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D.
Self-Administration | No
Product Website | https://tzieldhcp.com/